China Traditional Chinese Medicine (570.HK) - Will This Privatization Rumor Come True ?
379 Views08 Feb 2024 08:43
We once again heard privatization rumor of China TCM.Considering the integration trend of SOE, privatization is always in the plan of CNPGC, but we just don't know when it will actually be implemented
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Pre-IPO Beijing Yuanxin Technology Group (PHIP Update) - Risk of Overvaluation and Poor Profit Model15 Feb 2024
- I-Mab to Divest Chinese Assets and Business Operations for up to $80M - An Escape by Crafty Scheme14 Feb 2024
- China Healthcare Weekly (Feb.12) - New Pricing Mechanism for Drugs, China Biotech M&A, Medicilon13 Feb 2024
- China Traditional Chinese Medicine (570.HK) - Will This Privatization Rumor Come True ?08 Feb 2024
- Latest Impact of the US Biosecure Act on WuXi AppTec/WuXi Bio/WuXi XDC - China CXO Really Game Over?05 Feb 2024
- China Healthcare–A Pair Trade Between China TCM (570.HK) And Pientzehuang Pharmaceutical (600436.CH)06 Nov 2023
- China Traditional Chinese Medicine (570.HK) - The Privatization Rumor and the Outlook12 Dec 2022
x